Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer
Sujit S. Nair, Rachel Weil, Zachary Dovey, et al.
Urologic Clinics of North America (2020) Vol. 47, Iss. 4, pp. e17-e54
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Elena Okina, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 126
Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC
Jinhui Liu, Rui Geng, Senmiao Ni, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 27, pp. 1036-1055
Open Access | Times Cited: 58
Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model
Kun Zheng, Youlong Hai, Hongqi Chen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Immunotherapy for Bladder Cancer: Latest Advances and Ongoing Clinical Trials
Daniela F. Ward Grados, Hamed Ahmadi, Thomas S. Griffith, et al.
Immunological Investigations (2022) Vol. 51, Iss. 8, pp. 2226-2251
Open Access | Times Cited: 31
Molecular mechanisms of ferroptosis and its role in prostate cancer therapy
Shaokun Wang, Wei Wei, Ning Ma, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103732-103732
Open Access | Times Cited: 30
Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
Cláudia Martins‐Lima, Ugo Chianese, Rosaria Benedetti, et al.
Frontiers in Molecular Biosciences (2023) Vol. 9
Open Access | Times Cited: 21
The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer
Fei Long, Wei Wang, Shuo Li, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research
Mohammad Waseem, Bi‐Dar Wang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1093-1093
Open Access | Times Cited: 8
Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis
Zihan Deng, Binghui Li, Muyang Yang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma and in vitro validation
Yang Yu, Yuexi Huang, Chen Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 24
Preoperative systemic immune-inflammation index as a prognostic indicator for patients with urothelial carcinoma
Jianxiong Zheng, Peng Lei, Shaohua Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Intratumoural immunotherapy plus focal thermal ablation for localized prostate cancer
Denis Séguier, Eric S. Adams, Srinath Kotamarti, et al.
Nature Reviews Urology (2023) Vol. 21, Iss. 5, pp. 290-302
Closed Access | Times Cited: 13
Nanomedicine in Bladder Cancer Therapy
Adrianna Winnicka, Joanna Brzeszczyńska, Joanna Saluk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10388-10388
Open Access | Times Cited: 4
Tumor Microenvironment in Urothelial Carcinoma: Focus on Metastatic Disease
Federica Cosso, M. Catalano, Giandomenico Roviello, et al.
(2025), pp. 1-30
Closed Access
Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub
Chien‐Chang Kao, Jing-Wen Shih, Huong Thi Luu Kim Huynh, et al.
International Journal of Medical Sciences (2025) Vol. 22, Iss. 5, pp. 1194-1207
Open Access
Disulfidptosis related immune genes drive prognostic model development and tumor microenvironment characterization in bladder urothelial carcinoma
Shenchao Guo, Guangjia Lv, Hengyue Zhu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The application of emerging immunotherapy in the treatment of prostate cancer: progress, dilemma and promise
Jizhong Che, Yuanyuan Liu, Yangyang Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The role of immunotherapy in targeting tumor microenvironment in genitourinary cancers
Ecem Kalemoglu, Yash Jani, Kübra Canaslan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
SIGMAR1 screened by a GPCR-related classifier regulates endoplasmic reticulum stress in bladder cancer
Jingming Zhuang, Yang Wang, Xinyong Wu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Genitourinary cancer neoadjuvant therapies: current and future approaches
Sujit S. Nair, Dimple Chakravarty, Vaibhav G. Patel, et al.
Trends in cancer (2023) Vol. 9, Iss. 12, pp. 1041-1057
Open Access | Times Cited: 10
ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment
Wen-Gu Pan, Xiaoli Liu, Shuang‐De Liu
Medicine (2024) Vol. 103, Iss. 14, pp. e37590-e37590
Open Access | Times Cited: 3
From foes to friends: rethinking the role of lymph nodes in prostate cancer
Raghav Gupta, Chandan K. Das, Sujit S. Nair, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 11, pp. 687-700
Closed Access | Times Cited: 3
Data-mining-based biomarker evaluation and experimental validation of SHTN1 for bladder cancer
Yueying Wang, Jiajun Wang, Tao Zeng, et al.
Cancer Genetics (2024) Vol. 288-289, pp. 43-53
Open Access | Times Cited: 3
Modern Landscape of Innovative Technologies in Optimizing the Quality of Life of Cancer Patients
В Ф Чехун
Experimental Oncology (2025) Vol. 46, Iss. 4, pp. 281-288
Closed Access
Overcoming Immune Resistance in Prostate Cancer: Challenges and Advances
Miyad Movassaghi, Rainjade Chung, Christopher B. Anderson, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4757-4757
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top